Asthma Medications
Asthma medication plays a key role in how well you control your condition. There are two main types of treatment, each geared toward a specific goal.
Controller medications are the most important because they prevent asthma attacks. When you use these drugs, your airways are less inflamed and less likely to react to triggers.
Quick-relief medications -- also called rescue medications -- relax the muscles around your airway. If you have to use a rescue medication more than twice a week, your asthma isn’t well-controlled. But people who have exercise-induced asthma may use a quick-acting med called a beta-agonist before a workout.
The right medication should allow you to live an active and normal life. If your asthma symptoms aren’t controlled, ask your doctor to help you find a different treatment that works better.
- Controller Medications
- Quick-Relief Medications
- Long-Term Control Medications
- Inhalers, Nebulizers and Pills
- Asthma Medication Guidelines
Related Conference of Asthma Medications
17th International Conference on Chronic Obstructive Pulmonary Disease
14th International Conference on COPD Clinical Trials & Lung Care Advances
16th International Conference on Pulmonary & Respiratory Medicine
Asthma Medications Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma and COPD - COPD_2025 (Spain)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Chronic Obstructive Pulmonary Disease - COPD_2025 (Spain)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Co-Morbidities of COPD - COPD_2025 (Spain)
- COPD and Cardiovascular Diseases - COPD_2025 (Spain)
- COPD Complications - COPD_2025 (Spain)
- COPD Exacerbations - COPD_2025 (Spain)
- COPD Pathogenesis - COPD_2025 (Spain)
- COPD Therapeutics - COPD_2025 (Spain)
- COPD: Sign and Symptoms - COPD_2025 (Spain)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Depression and anxiety in COPD - COPD_2025 (Spain)
- Drug Discovery of COPD - COPD_2025 (Spain)
- Epidemiology of COPD - COPD_2025 (Spain)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Genetic risk factor of COPD - COPD_2025 (Spain)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Lung cancer - COPD_2025 (Spain)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Pathophysiology of COPD - COPD_2025 (Spain)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2025 (Spain)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Pulmonary diseases-treatment and therapies - COPD_2025 (Spain)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension - COPD_2025 (Spain)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Self-Management and Prevention of COPD - COPD_2025 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
- Types of COPD - COPD_2025 (Spain)

